首页> 外文学位 >Drug diffusion and structural design criteria for conventional and auxetic drug-eluting stents.
【24h】

Drug diffusion and structural design criteria for conventional and auxetic drug-eluting stents.

机译:常规和生长不良药物洗脱支架的药物扩散和结构设计标准。

获取原文
获取原文并翻译 | 示例

摘要

Most balloon angioplasty procedures include the insertion of tiny cylindrical wire mesh structures, called cardiovascular stents, to prevent the elastic recoil that follows arterial dilatation. The scaffolding characteristics of the stent provide strength to the artery wall. However, recognition of the stent as a foreign material triggers a human immune system response causing closure of the artery. This condition is known as restenosis.; A recent advancement to counteract restenosis is to employ drug-eluting stents to locally deliver immunosuppressant drugs. Currently, drug-eluting stents usually consist of a metal wire structure coated with a microporous polymer matrix or a nanoporous metal matrix structure. Either type of drug-eluting stent may also have a polymer top coat. The drug resides within the pores of the matrix, from which it diffuses into the adjacent arterial tissue. The polymer top coat controls the drug delivery rate to provide a more constant long term dosage.; In this project, Fick's law of diffusion in cylindrical coordinates was used to model the diffusion of immunosuppressant drug molecules from the stent matrix into the adjacent arterial tissue. Extensive parametric analyses were performed to determine the minimum required stent matrix thickness to provide sufficient drug delivery so that the stent retains its efficacy.; In addition to efficient drug delivery, the drug-eluting stent must also exhibit high circumferential strength to support the arterial wall and low flexural rigidity for maneuverability during deployment.; In this project, an analytical procedure was developed to estimate the circumferential and the flexural stiffnesses of stents using the invariant properties of orthotropic materials. These invariant properties were determined from apparent micromechanical stiffnesses using a mechanics of materials approach. Furthermore, a unique auxetic (negative Poisson's ratio) stent structure is proposed that exhibits high circumferential strength in its expanded configuration and low flexural rigidity in its crimped configuration.; Results generated with the analytical diffusion model, developed in this project, compare favorably with previously published clinical data. The circumferential and flexural stiffnesses estimated using the analytical procedure developed in this project compare favorably with the results from rigorous finite element analyses and previously published experimental data.
机译:大多数球囊血管成形术包括插入细小的圆柱形金属丝网结构,称为心血管支架,以防止动脉扩张后的弹性后座力。支架的脚手架特性为动脉壁提供了强度。但是,将支架识别为异物会触发人体免疫系统反应,从而导致动脉闭合。这种情况称为再狭窄。对抗再狭窄的最新进展是采用药物洗脱支架来局部递送免疫抑制剂药物。当前,药物洗脱支架通常由涂覆有微孔聚合物基质或纳米孔金属基质结构的金属线结构组成。每种类型的药物洗脱支架都可以具有聚合物面涂层。药物驻留在基质的孔中,从中扩散到相邻的动脉组织中。聚合物外涂层控制药物的输送速率以提供更恒定的长期剂量。在这个项目中,使用圆柱坐标中的菲克扩散定律来模拟免疫抑制剂药物分子从支架基质到邻近动脉组织的扩散。进行了广泛的参数分析,以确定提供足够药物输送所需的最小支架基质厚度,以使支架保持其功效。除了有效的药物输送以外,药物洗脱支架还必须具有高周向强度以支撑动脉壁,并具有较低的挠曲刚度,以在展开过程中具有可操作性。在该项目中,开发了一种分析方法,以利用正交各向异性材料的不变特性来估算支架的周向和弯曲刚度。这些不变性质是使用材料力学方法根据表观的微机械刚度确定的。此外,提出了一种独特的膨胀(泊松比为负)支架结构,该支架结构在其扩张构造中具有高周向强度,在其卷曲构造中具有低抗弯刚度。该项目开发的分析扩散模型产生的结果与以前发表的临床数据相比具有优势。使用该项目开发的分析程序估算的圆周刚度和弯曲刚度与严格的有限元分析和先前发表的实验数据的结果相比具有优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号